HomeCompareBOMXF vs MRK

BOMXF vs MRK: Dividend Comparison 2026

BOMXF yields 4.99% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BOMXF wins by $125.7K in total portfolio value
10 years
BOMXF
BOMXF
● Live price
4.99%
Share price
$2.11
Annual div
$0.11
5Y div CAGR
38.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$182.5K
Annual income
$71,168.99
Full BOMXF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — BOMXF vs MRK

📍 BOMXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBOMXFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BOMXF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BOMXF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BOMXF
Annual income on $10K today (after 15% tax)
$423.79/yr
After 10yr DRIP, annual income (after tax)
$60,493.64/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, BOMXF beats the other by $52,165.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BOMXF + MRK for your $10,000?

BOMXF: 50%MRK: 50%
100% MRK50/50100% BOMXF
Portfolio after 10yr
$119.6K
Annual income
$40,483.56/yr
Blended yield
33.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BOMXF
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
11.9
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BOMXF buys
0
MRK buys
0
No recent congressional trades found for BOMXF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBOMXFMRK
Forward yield4.99%2.76%
Annual dividend / share$0.11$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR38.1%32.7%
Portfolio after 10y$182.5K$56.8K
Annual income after 10y$71,168.99$9,798.13
Total dividends collected$148.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: BOMXF vs MRK ($10,000, DRIP)

YearBOMXF PortfolioBOMXF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,389$688.54$11,206$366.19+$183.00BOMXF
2$13,198$1,012.06$12,650$502.35+$548.00BOMXF
3$15,635$1,513.73$14,407$694.19+$1.2KBOMXF
4$19,044$2,314.54$16,585$967.82+$2.5KBOMXF
5$24,016$3,638.59$19,342$1,363.89+$4.7KBOMXF
6$31,619$5,922.14$22,913$1,947.19+$8.7KBOMXF
7$43,896$10,063.27$27,662$2,823.89+$16.2KBOMXF
8$65,000$18,031.05$34,159$4,173.35+$30.8KBOMXF
9$104,010$34,460.20$43,337$6,308.80+$60.7KBOMXF
10$182,460$71,168.99$56,776$9,798.13+$125.7KBOMXF

BOMXF vs MRK: Complete Analysis 2026

BOMXFStock

Bolsa Mexicana de Valores, S.A.B. de C.V. operates cash, listed derivatives, and OTC markets for various asset classes, including equities, fixed income, and exchange traded funds. The company also provides custody, clearing and settlement facilities, and data products for the local and international financial community. It operates the Mexican Stock Exchange that provides facilities and mechanisms as an aid in the relationship of the securities supply and demand, credit certificates, and other documents registered at the National Securities Registry, as well as services for underwriting, offering, and the exchange of the aforementioned securities; and publishes, provides, and maintains information of the securities listed at the Mexican Exchange and at the International Quotations System to the general public. The company's exchange also issues regulation that sets standards, and operative and conduct guidelines to promote fair and equitable market practices at the securities market; and guards its observation and impose disciplinary and corrective measures in case of lack of fulfillment for brokerage firms and the issuers with listed securities at the Mexican Exchange. In addition, it offers central securities depository, custody and settlement of securities, clearing house, price valuation, and risk management services. The company is based in Mexico City, Mexico.

Full BOMXF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BOMXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BOMXF vs SCHDBOMXF vs JEPIBOMXF vs OBOMXF vs KOBOMXF vs MAINBOMXF vs JNJBOMXF vs ABBVBOMXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.